Newsroom
October 15, 2008
Francisco G. Cigarroa, M.D., president of The University of Texas Health Science Center at San Antonio, invites the university community and the public to the Seventh Annual Presidential Distinguished Lecture, this year presented by C. Ronald Kahn, M.D., of the Joslin Diabetes Center in Boston.
June 25, 2008
Issues in cardiology will be the topic this week as a group of state legislators visit The University of Texas Health Science Center at San Antonio.
June 12, 2008
Studies of insulin resistance, development of frontline therapies shape his legacy.
June 12, 2008
In a research study of hundreds of patients facing the prospect of developing type 2 diabetes, the oral drug pioglitazone (brand name: Actos®) reduced the rate of conversion to the disease by 81 percent in the active therapy group compared to those taking a placebo, the study leader, Ralph A. DeFronzo, M.D., reported June 9 during the 68th Scientific Sessions of the American Diabetes Association in San Francisco.
May 14, 2008
A three-year research study by The University of Texas Health Science Center at San Antonio seeks volunteers ages 18-30 and 65 and older to compare levels of a protein called NFkB (NF-kappa-B).
January 24, 2008
World-renowned diabetes researcher Ralph A. DeFronzo, M.D., is the 2008 Presidential Distinguished Scholar at The University of Texas Health Science Center at San Antonio.